A novel class of Ribosome Modulating Agents (RMAs) targets ribosome heterogeneity in a subset of colorectal cancers. (October 2022) - Badarinarayana, V.; Terzo, E.; Apte, S.; Padhye, S.; Rashed, S.; Austin, W.; Caponegro, M.; Reddy, A.; Wang, C.; Clark, R.; Sidransky, D.; Modur, V.